Divalproex Sodium — Antiepileptic (valproate). Study the mechanism, listed uses and warnings from the US label on one sourced card.
Generic name
Divalproex Sodium
Class
Antiepileptic (valproate)
Mechanism
Dissociates to valproate; mechanism not established, possibly increased brain GABA concentrations.
Used for
Acute manic or mixed episodes associated with bipolar disorder in adults; Complex partial seizures or simple/complex absence seizures in adults and children aged 10 years and older; adjunctive therapy for multiple seizure types including absence seizures; Migraine prevention in adults; not treatment of an acute migraine
Potentially fatal liver injury, especially during the first six months and in high-risk groups; major birth defects and neurodevelopmental harm after fetal exposure; and potentially fatal pancreatitis. Migraine prevention is contraindicated during pregnancy and in women of childbearing potential without effective contraception. Pregnancy-related use for epilepsy or bipolar disorder is restricted to cases where alternatives fail or are unacceptable.
Warnings
Birth defects / decreased IQ after in utero exposure; Pancreatitis; Suicidal behavior or ideation
Brand questions use only name pairings verified against the linked product source. Unverified pairings are withheld from these questions; the other study content remains available.
Label date: 20260812 · For learning, not clinical decisions. US label and brand information; always consult the current source.
Source snapshot checked: 2026-10-21. The source document and selected fields were compared. The complete card has not had an independent clinical review.
Mechanism: Non-ergoline dopamine agonist thought to act by stimulating D2 receptors in the caudate-putamen.
On both cards: Common side effects — Nausea; Somnolence
Only on the Ropinirole card: Used for — Parkinson's disease; Moderate-to-severe primary restless legs syndrome · Common side effects — Dizziness; Syncope; Hallucinations · Warnings — Falling asleep during daily activities; Orthostatic hypotension / syncope; Impulse control / compulsive behaviors · Interactions — CYP1A2 inhibitors or inducers; Hormone replacement therapy; Dopamine antagonists
Mechanism: Non-ergot dopamine agonist with in-vitro activity at D2-family receptors and greater affinity for D3 than D2 or D4. The precise mechanisms in Parkinson disease and restless legs syndrome are unknown.
On both cards: Common side effects — Nausea; Somnolence
Only on the Pramipexole card: Used for — Parkinson disease in adults; Moderate-to-severe primary restless legs syndrome in adults · Common side effects — Dizziness; Insomnia; Hallucinations · Warnings — Falling asleep during daily activities; Orthostatic hypotension; Impulse control / compulsive behaviors · Interactions — Dopamine antagonists (neuroleptics, metoclopramide)
Mechanism: Activity is mainly mediated by MHD. The precise anti-seizure mechanism is unknown; in-vitro studies indicate voltage-sensitive sodium-channel blockade that stabilizes hyperexcited membranes.
On both cards: Common side effects — Nausea; Somnolence
Only on the Oxcarbazepine card: Used for — Partial-onset seizures: monotherapy or adjunctive treatment in adults; Partial-onset seizures: monotherapy in children aged 4 years and older; Partial-onset seizures: adjunctive treatment in children aged 2 years and older · Common side effects — Dizziness; Diplopia; Fatigue · Warnings — Hyponatremia; Serious dermatological reactions; Cross-hypersensitivity to carbamazepine · Interactions — Phenytoin; Strong CYP inducers (e.g., carbamazepine); Hormonal contraceptives
An item counts as shared only when both cards use the same wording. If a card does not list an item, that is not a statement that the effect never occurs.
Capsera